Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01422707

Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess

Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (CBS003)

Status
Withdrawn
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Virginia · Academic / Other
Sex
Female
Age
7 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Short term hydrocortisone to test whether improves excess androgen production from adrenal gland and ovaries

Detailed description

This study will test whether short-term suppression of adrenal function can ameliorate androgen (male hormone) overproduction in overweight girls with androgen excess. The investigators hypothesize that one month of oral hydrocortisone administration will improve androgen levels in girls with adrenal androgen overproduction. Specifically, this intervention will improve androgen levels after adrenal stimulation testing with adrenocorticotropin hormone (ACTH).

Conditions

Interventions

TypeNameDescription
DRUGHydrocortisone10 mg/m2/per day PO at bedtime (X4 weeks)

Timeline

Start date
2018-01-19
Primary completion
2018-07-17
Completion
2018-07-17
First posted
2011-08-24
Last updated
2018-07-19

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT01422707. Inclusion in this directory is not an endorsement.